Microbial pathogens have developed various stratagems for modulating and/or circumventing the host’s innate and adaptive immunity. Hence, certain virulence factors can be viewed as potential therapeutic agents for human immunopathological diseases. This is the case for virulence plasmid-encoded proteins from pathogenic Yersiniae that inhibit the host’s inflammatory response by interfering with various cellular signaling pathways.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abad, C., Juarranz, Y., Martinez C., Arranz A., Rosignoli, F., Garcia-Gomez, M., Leceta, J. and Gomariz, R.P. (2005) DNa array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP. Inflamm. Bowel Dis. 11, 674-684.
Bouma, G. and Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533.
Braat, H., Rottiers, P., Hommes, D.W., Huyghebaert, N., Remaut, E., Remon, J.P., van Deventer, S.J., Neirynck, S., Peppelenbosch, M.P. and Steidler, L. (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroen-terol. Hepatol. 4, 754-759.
Brubaker, R.R. (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and Lcrv (V antigen). Infect. Immun. 71, 3673-3681.
Foligné, B., Nutten, S., Steidler, L., Dennin, V., Goudercourt, D., Mercenier, A. and Pot, B. (2006) Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbi-ological aspects. Dig. Dis. Sci. 51, 390-400.
Korzenik, J.R. and Podolsky, D.K. (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat. Rev. Drug Discov. 5, 197-209.
Le Loir, Y., Azevedo, V., Oliveira, S.C., Freitas, D.A., Miyoshi, A., Bermudez-Humaran, L.G., Nouaille, S., Ribeiro, L.A., Leclercq, S., Gabriel, J.E., Guimaraes, V.D., Oliveira M.N., Charlier, C., Gautier, M. and Langella P. (2005) Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb. Cell. Fact. 4, 2.
Marceau, M., Dubuquoy, L., Caucheteux-Rousseaux, C., Foligné, B., Desreumaux, P. and Simonet, M. (2004) Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse. Infect. Immun. 72, 2438-2441.
Nakajima, R., Motin, V.L. and Brubaker, R.R. (1995). Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63, 3021-3029.
Podolsky, D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
Sing, A., Rost, D., Tvardovskaia, N., Roggenkamp, A., Wiedemann, A., Kirschning, C.J., Aepfelbacher, M. and Heesemann, J. (2002) Yersinia V-antigen exploits toll-like recep tor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196, 1017-1024.
Viboud, G.I. and Bliska J. B. (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89.
Wallace, J.L., MacNaughton, W.K., Morris, G.P. and Beck, P.L. (1989) Inhibition of leukot-riene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96, 29-36.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Foligné, B. et al. (2007). Therapeutic Potential of Yersinia Anti-Inflammatory Components. In: Perry, R.D., Fetherston, J.D. (eds) The Genus Yersinia. Advances In Experimental Medicine And Biology, vol 603. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72124-8_33
Download citation
DOI: https://doi.org/10.1007/978-0-387-72124-8_33
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72123-1
Online ISBN: 978-0-387-72124-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)